Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
CRO
WuXi AppTec posts sales decline but picks up new business in Q3
With the specter of the BIOSECURE Act clouding its future, China’s WuXi AppTec sustained its fourth straight quarter with a revenue decline.
Kevin Dunleavy
Oct 29, 2024 8:25am
China-based biotech plans ph. 3 after seeing midstage eye data
Oct 22, 2024 10:37am
Eli Lilly unveils 2 new research centers in China
Oct 15, 2024 5:30pm
Chinese insulin maker’s GLP-1 bests Ozempic in ph. 2, company says
Oct 15, 2024 11:12am
InnoCare's TYK2 inhibitor holds its own in ph. 2 psoriasis trial
Oct 9, 2024 9:10am
Zephyrm seeks Hong Kong IPO to fund phase 3 cell therapy trials
Oct 2, 2024 8:19am
